Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antiphospholipid antibodies and platelets.

A De Jong1, V Ziboh, D Robbins

  • 1Departments of Internal Medicine and Dermatology, School of Medicine, University of California, Davis, CA 95616, USA.

Current Rheumatology Reports
|December 21, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pyocyanin produced by <i>Pseudomonas aeruginosa</i> creates legacy effects that promote antibiotic resistance evolution in enterococci.

Antimicrobial agents and chemotherapy·2026
Same author

Predictors of pain during phacoemulsification under local sedation: A multicentric study.

Journal francais d'ophtalmologie·2024
Same author

Cytomegalovirus infection in intensive care unit patients with hematological malignancies: Characteristics and clinical outcomes.

Journal of critical care·2024
Same author

Pilot implementation of MiLES: a web-based intervention targeted at managers with the aim of enhancing the successful return to work of employees with cancer.

Acta oncologica (Stockholm, Sweden)·2023
Same author

Lymphocele following lymph node dissection in cervical and endometrial cancer: A systematic review and meta-analysis.

Gynecologic oncology·2023
Same author

Guidelines of the French Society of ENT (SFORL): Drug-induced sleep endoscopy in adult obstructive sleep apnea syndrome.

European annals of otorhinolaryngology, head and neck diseases·2022

Antiphospholipid syndrome (APS) involves antiphospholipid-binding antibodies (aPL). This review explores how anticardiolipin antibodies (aCL) and beta-2 glycoprotein-I (beta(2)GP-I) complexes may interact with platelets, impacting APS.

Area of Science:

  • Immunology
  • Hematology
  • Pathophysiology

Background:

  • Antiphospholipid syndrome (APS) is characterized by antiphospholipid antibodies (aPL).
  • The precise pathogenic mechanisms of APS remain unclear.
  • Key components include anticardiolipin antibodies (aCL), beta-2 glycoprotein-I (beta(2)GP-I), and platelets.

Purpose of the Study:

  • To review the physiology of aPL, beta(2)GP-I, and platelets in APS.
  • To discuss current hypotheses on the role of aCL/beta(2)GP-I complexes in platelet activation.
  • To elucidate the relationship between these complexes and platelet aggregation.

Main Methods:

  • Literature review of existing research on APS, aPL, beta(2)GP-I, and platelet function.
  • Synthesis of current understanding regarding the interaction between aCL/beta(2)GP-I complexes and platelets.

Related Experiment Videos

  • Exploration of proposed pathogenic pathways.

    • Main Results:

    • Antiphospholipid-binding antibodies (aPL), particularly anticardiolipin antibodies (aCL), are central to APS serology.
    • Beta-2 glycoprotein-I (beta(2)GP-I) acts as a cofactor for aCL.
    • The interaction between aCL/beta(2)GP-I complexes and blood platelets is a proposed mechanism in APS pathogenesis, though not fully understood.

    Conclusions:

    • The interplay between aCL/beta(2)GP-I complexes and platelets is critical for understanding APS.
    • Further research is needed to clarify the exact mechanisms of platelet aggregation in APS.
    • Understanding these interactions may lead to improved diagnostic and therapeutic strategies for APS.